For immunosuppressed patients with nonspecific symptoms due to invasive fungal infections (IFI), diagnosis remains a challenge. Limitations of traditional laboratory testing often result in delayed diagnosis, which is associated with high mortality rates.
Mayo Clinic Laboratories offers rapid in vitro diagnostic screening tests for IFI caused by various fungi, including Aspergillus species, Fusarium species, and Candida species, among others.
Invasive fungal infections Test menu
Fungal biomarker detection, used in conjunction with conventional testing methods, can help to make a presumptive diagnosis of fungal infection prior to symptom progression.
Recommended laboratory test pairings are frequently used in conjunction with BDG testing.
Polymerase chain reaction
Fill out the form below and one of our specialists will be in touch.